Global mAb Biosimilar Market Research Report 2016

Publisher Name :
Date: 05-Oct-2016
No. of pages: 113

Notes:

Production, means the output of mAb Biosimilar

Revenue, means the sales value of mAb Biosimilar

This report studies mAb Biosimilar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

- Baxter

- GSK

- Merck

- Novartis

- Pfizer

- Roche Holding

- Sanofi

- Mitsubishi Tanabe Pharma

- Hospira

- Alvartis Pharma

- Allergan

- Amega Biotech

- Biogen

- LG Lifesciences

- Samsung Biologics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of mAb Biosimilar in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of mAb Biosimilar in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global mAb Biosimilar Market Research Report 2016

Table of Contents
Global mAb Biosimilar Market Research Report 2016
1 mAb Biosimilar Market Overview
1.1 Product Overview and Scope of mAb Biosimilar
1.2 mAb Biosimilar Segment by Type
1.2.1 Global Production Market Share of mAb Biosimilar by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 mAb Biosimilar Segment by Application
1.3.1 mAb Biosimilar Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 mAb Biosimilar Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of mAb Biosimilar (2011-2021)
2 Global mAb Biosimilar Market Competition by Manufacturers
2.1 Global mAb Biosimilar Production and Share by Manufacturers (2015 and 2016)
2.2 Global mAb Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global mAb Biosimilar Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers mAb Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 mAb Biosimilar Market Competitive Situation and Trends
2.5.1 mAb Biosimilar Market Concentration Rate
2.5.2 mAb Biosimilar Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global mAb Biosimilar Production, Revenue (Value) by Region (2011-2016)
3.1 Global mAb Biosimilar Production and Market Share by Region (2011-2016)
3.2 Global mAb Biosimilar Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
4 Global mAb Biosimilar Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global mAb Biosimilar Consumption by Regions (2011-2016)
4.2 North America mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
5 Global mAb Biosimilar Production, Revenue (Value), Price Trend by Type
5.1 Global mAb Biosimilar Production and Market Share by Type (2011-2016)
5.2 Global mAb Biosimilar Revenue and Market Share by Type (2011-2016)
5.3 Global mAb Biosimilar Price by Type (2011-2016)
5.4 Global mAb Biosimilar Production Growth by Type (2011-2016)
6 Global mAb Biosimilar Market Analysis by Application
6.1 Global mAb Biosimilar Consumption and Market Share by Application (2011-2016)
6.2 Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global mAb Biosimilar Manufacturers Profiles/Analysis
7.1 Baxter
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 mAb Biosimilar Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 GSK
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 mAb Biosimilar Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Merck
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 mAb Biosimilar Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Novartis
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 mAb Biosimilar Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Pfizer
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 mAb Biosimilar Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Roche Holding
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 mAb Biosimilar Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Sanofi
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 mAb Biosimilar Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Mitsubishi Tanabe Pharma
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 mAb Biosimilar Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Hospira
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 mAb Biosimilar Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Alvartis Pharma
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 mAb Biosimilar Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Allergan
7.12 Amega Biotech
7.13 Biogen
7.14 LG Lifesciences
7.15 Samsung Biologics
8 mAb Biosimilar Manufacturing Cost Analysis
8.1 mAb Biosimilar Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of mAb Biosimilar
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 mAb Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global mAb Biosimilar Market Forecast (2016-2021)
12.1 Global mAb Biosimilar Production, Revenue Forecast (2016-2021)
12.2 Global mAb Biosimilar Production, Consumption Forecast by Regions (2016-2021)
12.3 Global mAb Biosimilar Production Forecast by Type (2016-2021)
12.4 Global mAb Biosimilar Consumption Forecast by Application (2016-2021)
12.5 mAb Biosimilar Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of mAb Biosimilar
Figure Global Production Market Share of mAb Biosimilar by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table mAb Biosimilar Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure China mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure India mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global mAb Biosimilar Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global mAb Biosimilar Production of Key Manufacturers (2015 and 2016)
Table Global mAb Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 mAb Biosimilar Production Share by Manufacturers
Figure 2016 mAb Biosimilar Production Share by Manufacturers
Table Global mAb Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global mAb Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global mAb Biosimilar Revenue Share by Manufacturers
Table 2016 Global mAb Biosimilar Revenue Share by Manufacturers
Table Global Market mAb Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market mAb Biosimilar Average Price of Key Manufacturers in 2015
Table Manufacturers mAb Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers mAb Biosimilar Product Type
Figure mAb Biosimilar Market Share of Top 3 Manufacturers
Figure mAb Biosimilar Market Share of Top 5 Manufacturers
Table Global mAb Biosimilar Production by Regions (2011-2016)
Figure Global mAb Biosimilar Production and Market Share by Regions (2011-2016)
Figure Global mAb Biosimilar Production Market Share by Regions (2011-2016)
Figure 2015 Global mAb Biosimilar Production Market Share by Regions
Table Global mAb Biosimilar Revenue by Regions (2011-2016)
Table Global mAb Biosimilar Revenue Market Share by Regions (2011-2016)
Table 2015 Global mAb Biosimilar Revenue Market Share by Regions
Table Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Global mAb Biosimilar Consumption Market by Regions (2011-2016)
Table Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)
Figure Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)
Figure 2015 Global mAb Biosimilar Consumption Market Share by Regions
Table North America mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Europe mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table China mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Japan mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table India mAb Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Global mAb Biosimilar Production by Type (2011-2016)
Table Global mAb Biosimilar Production Share by Type (2011-2016)
Figure Production Market Share of mAb Biosimilar by Type (2011-2016)
Figure 2015 Production Market Share of mAb Biosimilar by Type
Table Global mAb Biosimilar Revenue by Type (2011-2016)
Table Global mAb Biosimilar Revenue Share by Type (2011-2016)
Figure Production Revenue Share of mAb Biosimilar by Type (2011-2016)
Figure 2015 Revenue Market Share of mAb Biosimilar by Type
Table Global mAb Biosimilar Price by Type (2011-2016)
Figure Global mAb Biosimilar Production Growth by Type (2011-2016)
Table Global mAb Biosimilar Consumption by Application (2011-2016)
Table Global mAb Biosimilar Consumption Market Share by Application (2011-2016)
Figure Global mAb Biosimilar Consumption Market Share by Application in 2015
Table Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
Figure Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter mAb Biosimilar Market Share (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK mAb Biosimilar Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck mAb Biosimilar Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis mAb Biosimilar Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer mAb Biosimilar Market Share (2011-2016)
Table Roche Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Holding mAb Biosimilar Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi mAb Biosimilar Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma mAb Biosimilar Market Share (2011-2016)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira mAb Biosimilar Market Share (2011-2016)
Table Alvartis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alvartis Pharma mAb Biosimilar Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mAb Biosimilar
Figure Manufacturing Process Analysis of mAb Biosimilar
Figure mAb Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015
Table Major Buyers of mAb Biosimilar
Table Distributors/Traders List
Figure Global mAb Biosimilar Production and Growth Rate Forecast (2016-2021)
Figure Global mAb Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global mAb Biosimilar Production Forecast by Regions (2016-2021)
Table Global mAb Biosimilar Consumption Forecast by Regions (2016-2021)
Table Global mAb Biosimilar Production Forecast by Type (2016-2021)
Table Global mAb Biosimilar Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Global Longum Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Longum market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Longum in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southe......
  • Global Porcine Gelatin Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 104
    Notes: Production, means the output of Porcine Gelatin Revenue, means the sales value of Porcine Gelatin This report studies Porcine Gelatin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Gelita - Rousselot - PB Gelatins - Nitta Gelatin - GELCO......
  • Global Optical Colposcopy Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 125
    Notes: Production, means the output of Optical Colposcopy Revenue, means the sales value of Optical Colposcopy This report studies Optical Colposcopy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Leisegang - Welch Allyn - Philips - Olympus - Zeiss......
  • Global Cervical Cancer Diagnostic Tests Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 124
    Notes: Production, means the output of Cervical Cancer Diagnostic Tests Revenue, means the sales value of Cervical Cancer Diagnostic Tests This report studies Cervical Cancer Diagnostic Tests in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Abbott Laboratories - BD......
  • Global Bovine Source Gelatin Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 114
    Notes: Production, means the output of Bovine Source Gelatin Revenue, means the sales value of Bovine Source Gelatin This report studies Bovine Source Gelatin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Gelita - Rousselot - PB Gelatins - Nitta Gelatin......
  • Global H7N9 Vaccine Sales Market Report 2017
    Published: 27-Feb-2017        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of H7N9 Vaccine Revenue, means the sales value of H7N9 Vaccine This report studies sales (consumption) of H7N9 Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Beijing Tiantan Biological Products - Hualan Bio - Sinovac Market S......
  • Global Polio Vaccines Sales Market Report 2017
    Published: 27-Feb-2017        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Polio Vaccines Revenue, means the sales value of Polio Vaccines This report studies sales (consumption) of Polio Vaccines in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Astellas Pharma - CSL - Emergent BioSolutions - GlaxoSmithKline......
  • Global Vegetarian Softgel Capsules Market Research Report 2017
    Published: 27-Feb-2017        Price: US 2900 Onwards        Pages: 114
    The Vegetarian softgel capsules industry concentration is high; there are more than one hundreds manufacturers in the world, and high-end products mainly from U.S. and Western European. In the world wide, giant manufactures mainly distribute in American and Europe. In order to meet the strong increasing market demand. The Sales of Vegetarian softgel capsules increases from M Capsules in 2012 to M Capsules in 2016, at a CAGR of more than 8.7%. The sales revenue of Vegetarian softgel capsul......
  • China Vegetable Capsules Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 25-Feb-2017        Price: US 4480 Onwards        Pages: 124
    Pill is a common part of many people's lives for pharmaceutical use or as health Supplements, It has two main forms of tablets and capsules. Tablets were the most popular way to take medicine for quite some time. While since some characters such as hard to swallow and slice, too many additives and so on, most people tend to switch to capsules from the industrialization era on when capsule shells technologies and filling machines have been developed. Scope of the Report: Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs